A detailed history of Simplify Asset Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Simplify Asset Management Inc. holds 19,082 shares of LLY stock, worth $15.2 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
19,082
Previous 19,082 -0.0%
Holding current value
$15.2 Million
Previous $16.9 Million -0.0%
% of portfolio
0.9%
Previous 0.9%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $5.92 Million - $7.36 Million
7,670 Added 67.21%
19,082 $16.9 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $2.44 Million - $3.06 Million
3,371 Added 41.92%
11,412 $10.3 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $2.3 Million - $3.08 Million
3,892 Added 93.81%
8,041 $6.26 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $402,295 - $474,253
-766 Reduced 15.58%
4,149 $2.42 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $553,807 - $763,508
-1,274 Reduced 20.58%
4,915 $2.64 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $263,756 - $352,672
752 Added 13.83%
6,189 $2.9 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $688,045 - $808,076
-2,215 Reduced 28.95%
5,437 $1.87 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $198,074 - $230,796
616 Added 8.75%
7,652 $2.8 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $599,779 - $683,511
2,023 Added 40.36%
7,036 $2.28 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $379,351 - $445,414
1,361 Added 37.27%
5,013 $1.63 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $428,543 - $532,571
1,826 Added 100.0%
3,652 $1.05 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $410,576 - $509,527
1,826 New
1,826 $504,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.